Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $21.90B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: STE stock price vs KMB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KMB's multiple
Needs KMB P/E.
Implied fair value · at STE's multiple
Needs STE P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: STE FY 2026 (ended Mar 31, 2026) · KMB FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 92% equity / 8% debt
Capital structure 83% equity / 17% debt · EV / Revenue 2.52x · EV / EBITDA 11.46x
KMB carries the larger enterprise value at $41.39B against $23.83B; KMB trades on the lower EV / Revenue multiple (2.52x vs 4.01x); KMB on the lower EV / EBITDA (11.46x vs 15.56x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
STERIS plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
KIMBERLY-CLARK CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.27x
4.77x
Net debt / EBITDA
Leverage against operating earnings
—
1.79x
Cash and equivalents
Liquid reserves on the balance sheet
—
$688.00M
Total debt
Interest-bearing obligations outstanding
$1.93B
$7.17B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Johnson & Johnson
STE vs JNJ
BAXTER INTERNATIONAL INC
STE vs BAX
BECTON DICKINSON & CO
STE vs BDX
ZIMMER BIOMET HOLDINGS, INC.
STE vs ZBH
Procter & Gamble Company
STE vs PG
COLGATE PALMOLIVE CO
STE vs CL
CLOROX CO /DE/
STE vs CLX
CHURCH & DWIGHT CO INC /DE/
STE vs CHD
EDGEWELL PERSONAL CARE Co
STE vs EPC
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
